|
1
|
Hu G, Drescher KM and Chen XM: Exosomal
miRNAs: Biological properties and therapeutic potential. Front
Genet. 3:562012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu X, Liu L, Xu Q, Wu P, Zuo X and Ji A:
MicroRNA as a novel drug target for cancer therapy. Expert Opin
Biol Ther. 12:573–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peng Y, Yu S, Li H, Xiang H, Peng J and
Jiang S: MicroRNAs: Emerging roles in adipogenesis and obesity.
Cell Signal. 26:1888–1896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goretti E, Zangrando J, Wagner DR and
Devaux Y: Unity is strength - a panel of 4 microRNAs decreases
cardiomyocyte hypertrophy. Int J Cardiol. 182:62–64. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
El-Diwany R, Wasilewski LN, Witwer KW,
Bailey JR, Page K, Ray SC, Cox AL, Thomas DL and Balagopal A: Acute
Hepatitis C virus infection induces consistent changes in
circulating microRNAs that are associated with nonlytic hepatocyte
release. J Virol. 89:9454–9464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shrivastava S, Petrone J, Steele R, Lauer
GM, Di Bisceglie AM and Ray RB: Up-regulation of circulating
miR-20a is correlated with hepatitis C virus-mediated liver disease
progression. Hepatology. 58:863–871. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cai P, Gobert GN, You H, Duke M and
McManus DP: Circulating miRNAs: Potential novel biomarkers for
hepatopathology progression and diagnosis of schistosomiasis
japonica in two murine models. PLoS Negl Trop Dis. 9:e00039652015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fu Y, Yi Z, Wu X, Li J and Xu F:
Circulating microRNAs in patients with active pulmonary
tuberculosis. J Clin Microbiol. 49:4246–4251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Monk CE, Hutvagner G and Arthur JS:
Regulation of miRNA transcription in macrophages in response to
Candida albicans. PLoS One. 5:e136692010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li XY, Zhang K, Jiang ZY and Cai LH:
miR-204/miR-211 downregulation contributes to candidemia-induced
kidney injuries via derepression of Hmx1 expression. Life Sci.
102:139–144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Das Gupta M, Fliesser M, Springer J,
Breitschopf T, Schlossnagel H, Schmitt AL, Kurzai O, Hünniger K,
Einsele H and Löffler J: Aspergillus fumigatus induces microRNA-132
in human monocytes and dendritic cells. Int J Med Microbiol.
304:592–596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pfaller MA and Diekema DJ: Epidemiology of
invasive mycoses in North America. Crit Rev Microbiol. 36:1–53.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shikanai-Yasuda MA, Filho FeQ Telles,
Mendes RP, Colombo AL and Moretti ML: Guidelines in
paracoccidioidomycosis. Rev Soc Bras Med Trop. 39:297–310. 2006.(In
Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marques SA: Paracoccidioidomycosis. Clin
Dermatol. 30:610–615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:D140–D144. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reid G, Kirschner MB and van Zandwijk N:
Circulating microRNAs: Association with disease and potential use
as biomarkers. Crit Rev Oncol Hematol. 80:193–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Li L, Zhou Z, Wang N, Zhang CY and
Zen K: A pilot study of serum microRNA signatures as a novel
biomarker for occult hepatitis B virus infection. Med Microbiol
Immunol (Berl). 201:389–395. 2012. View Article : Google Scholar
|
|
19
|
Weiland M, Gao XH, Zhou L and Mi QS: Small
RNAs have a large impact: Circulating microRNAs as biomarkers for
human diseases. RNA Biol. 9:850–859. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Oliveira HC, Assato PA, Marcos CM,
Scorzoni L, de Paula E, Silva AC, Da Silva JF, Singulani JL,
Alarcon KM, Fusco-Almeida AM and Mendes-Giannini MJ:
Paracoccidioides-host Interaction: An overview on recent advances
in the Paracoccidioidomycosis. Front Microbiol. 6:13192015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cacere CR, Romano CC, Giannini MJ Mendes,
Duarte AJ and Benard G: The role of apoptosis in the
antigen-specific T cell hyporesponsiveness of
paracoccidioidomycosis patients. Clin Immunol. 105:215–222. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Verícimo MA, França KM, Arnholdt AC and
Kipnis TL: Increased apoptosis during the early phase of
experimental paracoccidioidomycosis as a phenotypic marker of
resistance. Microbes Infect. 8:2811–2820. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Silva SS, Tavares AH, Passos-Silva DG,
Fachin AL, Teixeira SM, Soares CM, Carvalho MJ, Bocca AL,
Silva-Pereira I, Passos GA and Felipe MS: Transcriptional response
of murine macrophages upon infection with opsonized
Paracoccidioides brasiliensis yeast cells. Microbes Infect.
10:12–20. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Del Vecchio A, Silva JF, Silva JL,
Andreotti PF, Soares CP, Benard G and Giannini MJ: Induction of
apoptosis in A549 pulmonary cells by two Paracoccidioides
brasiliensis samples. Mem Inst Oswaldo Cruz. 104:749–754. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fortes MR, Miot HA, Kurokawa CS, Marques
ME and Marques SA: Immunology of paracoccidioidomycosis. An Bras
Dermatol. 86:516–524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang B, Lu L and Zhang X, Ye W, Wu J, Xi
Q and Zhang X: hsa-miR-132 regulates apoptosis in non-small cell
lung cancer independent of acetylcholinesterase. J Mol Neurosci.
53:335–344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ni B, Rajaram MV, Lafuse WP, Landes MB and
Schlesinger LS: Mycobacterium tuberculosis decreases human
macrophage IFN-γ responsiveness through miR-132 and miR-26a. J
Immunol. 193:4537–4547. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kapinas K, Kessler C, Ricks T, Gronowicz G
and Delany AM: miR-29 modulates Wnt signaling in human osteoblasts
through a positive feedback loop. J Biol Chem. 285:25221–25231.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pereira CP, Bachli EB and Schoedon G: The
wnt pathway: A macrophage effector molecule that triggers
inflammation. Curr Atheroscler Rep. 11:236–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H, Sun Z, Wei W, Liu Z, Fleming J,
Zhang S, Lin N, Wang M, Chen M, Xu Y, et al: Identification of
serum microRNA biomarkers for tuberculosis using RNA-seq. PLoS One.
9:e889092014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rajaram MV, Ni B, Morris JD, Brooks MN,
Carlson TK, Bakthavachalu B, Schoenberg DR, Torrelles JB and
Schlesinger LS: Mycobacterium tuberculosis lipomannan blocks TNF
biosynthesis by regulating macrophage MAPK-activated protein kinase
2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci USA.
108:17408–17413. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gaziel-Sovran A, Segura MF, Di Micco R,
Collins MK, Hanniford D, Vega-Saenz de Miera E, Rakus JF, Dankert
JF, Shang S, Kerbel RS, et al: miR-30b/30d regulation of GalNAc
transferases enhances invasion and immunosuppression during
metastasis. Cancer Cell. 20:104–118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sabina S, Pulignani S, Rizzo M, Cresci M,
Vecoli C, Foffa I, Ait-Ali L, Pitto L and Andreassi MG: Germline
hereditary, somatic mutations and microRNAs targeting-SNPs in
congenital heart defects. J Mol Cell Cardiol. 60:84–89. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guan G, Zhang D, Zheng Y, Wen L, Yu D, Lu
Y and Zhao Y: microRNA-423-3p promotes tumor progression via
modulation of AdipoR2 in laryngeal carcinoma. Int J Clin Exp
Pathol. 7:5683–5691. 2014.PubMed/NCBI
|
|
35
|
Caldini CP, Xander P, Kioshima ÉS, Bachi
AL, de Camargo ZP, Mariano M and Lopes JD: Synthetic peptides mimic
gp75 from Paracoccidioides brasiliensis in the diagnosis of
paracoccidioidomycosis. Mycopathologia. 174:1–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Batista J Jr, de Camargo ZP, Fernandes GF,
Vicentini AP, Fontes CJ and Hahn RC: Is the geographical origin of
a Paracoccidioides brasiliensis isolate important for antigen
production for regional diagnosis of paracoccidioidomycosis?
Mycoses. 53:176–180. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Polakovičová M, Musil P, Laczo E, Hamar D
and Kyselovič J: Circulating microRNAs as potential biomarkers of
exercise response. Int J Mol Sci. 17:E15532016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim T and Reitmair A: Non-Coding RNAs:
Functional aspects and diagnostic utility in oncology. Int J Mol
Sci. 14:4934–4968. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Madhavan D, Cuk K, Burwinkel B and Yang R:
Cancer diagnosis and prognosis decoded by blood-based circulating
microRNA signatures. Front Genet. 4:1162013. View Article : Google Scholar : PubMed/NCBI
|
